200
Participants
Start Date
December 23, 2019
Primary Completion Date
June 2, 2026
Study Completion Date
June 2, 2026
zilucoplan (RA101495)
Daily subcutaneous (SC) injection
Mg0011 23, New York
Mg0011 47, New York
Mg0011 123, Great Neck
Mg0011 40, Pittsburgh
Mg0011 27, Washington D.C.
Mg0011 164, Charlottesville
Mg0011 22, Chapel Hill
Mg0011 135, Augusta
Mg0011 25, Tampa
Mg0011 41, Mobile
Mg0011 28, Cordova
Mg0011 38, Columbus
Mg0011 122, Cleveland
Mg0011 156, Indianapolis
Mg0011 33, Detroit
Mg0011 49, East Lansing
Mg0011 45, Milwaukee
Mg0011 134, Columbia
Mg0011 32, Kansas City
Mg0011 19, Dallas
Mg0011 131, Austin
Mg0011 39, Salt Lake City
Mg0011 116, Phoenix
Mg0011 117, Las Vegas
MG0011 4, Los Angeles
Mg0011 220, Pasadena
Mg0011 31, Irvine
Mg0011 160, San Francisco
Mg0011 154, Seattle
Mg0011 24, New Haven
Mg0011 188, Glenview
Mg0011 30, Buffalo
Mg0011 128, Charleston
Mg0011 11, Montreal
Mg0011 204, Lille
Mg0011 118, Nice
Mg0011 105, Paris
Mg0011 137, Strasbourg
Mg0011 150, Göttingen
Mg0011 129, Tübingen
Mg0011 132, Milan
Mg0011 126, Roma
Mg0011 151, Chiba
Mg0011 136, Hanamaki-shi
Mg0011 179, Kita-gun
Mg0011 153, Meguro-ku
Mg0011 146, Nagasaki
Mg0011 169, Narita
Mg0011 152, Sapporo
Mg0011 144, Sendai
Mg0011 163, Shinjuku-ku
Mg0011 141, Tokyo
Mg0011 140, Bergen
Mg0011 143, Oslo
Mg0011 195, Katowice
Mg0011 213, Katowice
Mg0011 192, Krakow
Mg0011 193, Krakow
Mg0011 211, Krakow
Mg0011 214, Lodz
Mg0011 205, Lublin
Mg0011 194, Nowa Sól
Mg0011 209, Poznan
Mg0011 201, Warsaw
Mg0011 210, Zabrze
Mg0011 133, Barcelona
Mg0011 168, Barcelona
Mg0011 138, Bilbao
Mg0011 119, Oxford
Mg0011 130, Sheffield
UCB Biopharma SRL
INDUSTRY